FAP Patient with Rare Mutation and Advancing Nerve, Heart Damage Treated Ably with Vyndaqel, Case Study Reports
A 60-year-old man with familial amyloid polyneuropathy (FAP), and quickly progressing nerve damage and heart disease, was found to carry a rare mutation in the TTR gene, a recent case report details. He responded well to treatment with Vyndaqel (tafamidis, by Pfizer), the medical team reported. The…